Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Product Unit Size | Cost | Quantity | Stock |
---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
Purity | ≥98% |
---|---|
Formula | C33H59N11O10 |
Formula Wt. | 769.90 |
Solubility | Soluble in water (2 mg/mL), acetonitrile. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Pyridine; PDE3 inhibitor.
Potential p53 activator or SIRT2 inhibitor.
Polyketide; CRM1 inhibitor.
Phytoalexin, indole found in cruciferous vegeta...
SV2A synaptic vesicle inhibitor.
Phenylpyrazoleanilide; IL-17 production inhibit...
Tropane alkaloid found in plants in the Solanac...
Acyl-CoA synthetase inhibitor.
Mixture of taxanes.
Protein translation inhibitor, peptidyl transfe...
Cyclic depsipeptide is a secondary metabolite i...
Histamine H1 antagonist.
Bcl-2, Bcl-xl, sialyl transferase inhibitor.
Peptide, vasopressin analog; V1/2 agonist.
Viral neuraminidase inhibitor, potential MAO-A ...
Peptide; FRP1 antagonist.
Histamine H2 inverse agonist.
Microtubule polymerization inhibitor, potential...
Dithiolopyrrolone; RNA polymerase inhibitor.
Steroid lactone produced by Withania somnifera;...